Search Results

You are looking at 41 - 50 of 576 items for :

  • Refine by Access: All x
Clear All
Full access

HSR19-109: The Healthy Days Measure in a Metastatic Castration-Resistant Prostate Cancer Population Treated With Novel Oral Therapies

Neil M. Schultz, Eleanor O. Caplan, Sam Wilson, Richard Sheer, and Brandon T. Suehs

Therapy-Fatigue (FACIT-Fatigue). Higher scores indicated higher HRQoL on all surveys, except the HDs scale, where higher numbers indicated lower HRQoL (ie, unhealthy days). Pearson correlations with SF-36 and HDs measures and SCA and FACIT-Fatigue were

Full access

Patient Experiences With Oral Chemotherapy: Adherence, Symptoms, and Quality of Life

Jamie M. Jacobs, Molly E. Ream, Nicole Pensak, Lauren E. Nisotel, Joel N. Fishbein, James J. MacDonald, Joanne Buzaglo, Inga T. Lennes, Steven A. Safren, William F. Pirl, Jennifer S. Temel, and Joseph A. Greer

-item Multidimensional Scale of Perceived Social Support (MSPSS), 22 with higher scores indicating greater perceived support. Fatigue The severity of cancer-related fatigue and its impact on functioning in the past 24 hours was measured using the 10

Full access

Survivorship: Cognitive Function, Version 1.2014

Crystal S. Denlinger, Jennifer A. Ligibel, Madhuri Are, K. Scott Baker, Wendy Demark-Wahnefried, Debra L. Friedman, Mindy Goldman, Lee Jones, Allison King, Grace H. Ku, Elizabeth Kvale, Terry S. Langbaum, Kristin Leonardi-Warren, Mary S. McCabe, Michelle Melisko, Jose G. Montoya, Kathi Mooney, Mary Ann Morgan, Javid J. Moslehi, Tracey O'Connor, Linda Overholser, Electra D. Paskett, Muhammad Raza, Karen L. Syrjala, Susan G. Urba, Mark T. Wakabayashi, Phyllis Zee, Nicole R. McMillian, and Deborah A. Freedman-Cass

play an important role in cognitive deficits after chemotherapy treatment. 2 , 5 , 13 , 29 , 30 In addition, fatigue and depression, common in cancer survivors, may negatively influence cognitive function, although several studies have found that

Full access

Phase II Trial of Symptom Screening With Targeted Early Palliative Care for Patients With Advanced Cancer

Camilla Zimmermann, Ashley Pope, Breffni Hannon, Monika K. Krzyzanowska, Gary Rodin, Madeline Li, Doris Howell, Jennifer J. Knox, Natasha B. Leighl, Srikala Sridhar, Amit M. Oza, Rebecca Prince, Stephanie Lheureux, Aaron R. Hansen, Anne Rydall, Brittany Chow, Leonie Herx, Christopher M. Booth, Deborah Dudgeon, Neesha Dhani, Geoffrey Liu, Philippe L. Bedard, Jean Mathews, Nadia Swami, and Lisa W. Le

every outpatient visit using the ESAS-r, with targeted EPC referral according to an algorithm based on symptom severity ( Figure 1 ). The ESAS-r assesses the severity of 9 common cancer symptoms (pain, fatigue, drowsiness, nausea, anxiety, depression

Full access

Adherence to the World Cancer Research Fund/American Institute for Cancer Research Guideline Is Associated With Better Health-Related Quality of Life Among Chinese Patients With Breast Cancer

Yuan-Yuan Lei, Suzanne C. Ho, Ashley Cheng, Carol Kwok, Chi-Kiu Iris Lee, Ka Li Cheung, Roselle Lee, Herbert H.F. Loong, Yi-Qian He, and Winnie Yeo

-specific HRQoL issues relevant to a broad spectrum of patients with cancer. 30 The QLQ-C30 included a global health and QoL domain, 5 functional domains (physical, role, emotional, cognitive, and social), 3 symptom domains (fatigue, nausea and vomiting, and pain

Full access

CLO19-035: Safety Profile and Adverse Events of Sunitinib as a First-Line Treatment for Advanced/Metastatic Clear-Cell Renal Cell Carcinoma: Pooled Analysis of Randomized Controlled Trials

Tarek Haykal, Babikir Kheiri, Varun Samji, Yazan Zayed, Ragheed Al-Dulaimi, Inderdeep Gakhal, Areeg Bala, Jason Sotzen, Ahmed Abdalla, and Ghassan Bachuwa

Foundation, Vienna, Austria). Results: We included 8 RCTs, with a total of 4,106 patients. The mean age was 62, with 66.44% males. Any grade AEs were reported in 72% of patients with the following frequencies: fatigue, 44%; diarrhea, 38%; nausea, 31%; hand

Full access

Sleep Disruption in Breast Cancer Patients and Survivors

Oxana Palesh, Arianna Aldridge-Gerry, Ayhan Ulusakarya, Elisabet Ortiz-Tudela, Lucile Capuron, and Pasquale F. Innominato

. For clinical diagnosis, these difficulties are typically associated with daytime impairment, such as fatigue or excessive sleepiness at least 3 times a week for 30 minutes or more for at least 1 month. Nearly 80% of women undergoing chemotherapy for

Full access

A Positive Psychology Intervention in Allogeneic Hematopoietic Stem Cell Transplantation Survivors (PATH): A Pilot Randomized Clinical Trial

Hermioni L. Amonoo, Elizabeth Daskalakis, Emma D. Wolfe, Michelle Guo, Christopher M. Celano, Brian C. Healy, Corey S. Cutler, Joseph H. Antin, William F. Pirl, Elyse R. Park, Heather S.L. Jim, Stephanie J. Lee, Thomas W. LeBlanc, Areej El-Jawahri, and Jeff C. Huffman

conditions, HSCT survivors grapple with enormous physical (eg, fatigue) and psychological symptoms (eg, anxiety) due to high-dose chemotherapy, with significant toxicities and potentially life-threatening complications during a prolonged hospitalization in

Full access

If Only It Were Simple

Rodger J. Winn

-controlled trial . J Clin Oncol 2001 ; 19 : 2865 - 2874 . 2 Berndt E Kallich J McDermott A . Reductions in anaemia and fatigue are associated with improvements in productivity in cancer patients receiving chemotherapy . Pharmacoeconomics 2005 ; 23

Full access

BRAF/MEK Dual Inhibitors Therapy in Progressive and Anaplastic Pleomorphic Xanthoastrocytoma: Case Series and Literature Review

Karolina Kata, Juan C. Rodriguez-Quintero, Octavio D. Arevalo, Jackie J. Zhang, Meenakshi Bidwai Bhattacharjee, Cornelius Ware, Antonio Dono, Roy Riascos-Castaneda, Nitin Tandon, Angel Blanco, Yoshua Esquenazi, Leomar Y. Ballester, Mark Amsbaugh, Arthur L. Day, and Jay-Jiguang Zhu

reported significant improvement in nutrition and ambulation. Due to new bony metastases, nivolumab and ipilimumab were added in January 2020 while maintaining encorafenib and binimetinib. While on this regimen for 4 months, with fatigue as the only AE